Skip to main content
Signal8

Nu-Med Plus, Inc. (NUMD) Form 8-K — Oct 20, 2026

$NUMDForm 8-KItems 1.01, 3.02, 9.01Filed Oct 20, 2026, 8:56 AM ET0001575872-26-000709Original filing

Nu-Med Plus entered into subscription agreements on October 19, 2026 with two accredited investors who purchased 171,232 shares of Series A Preferred Stock for an aggregate $450,000, or $2.628 per share. The raise is part of a best efforts, no minimum private placement capped at 190,258 shares or $500,000, terminating October 30, 2026 unless extended by the Board for up to 90 days. The same day, the company issued 50,000 Series A Preferred shares to an individual consultant for services.

Key figures

Gross Proceeds
450000
Offering Price
2.628
Shares Offered
171232
Max offering shares
190258
Max offering amount usd
500000
Minimum subscription usd
100000
Offering termination date
October 30, 2026
Shares issuable investor conversion
3424640
Consultant shares series a preferred
50000
Shares issuable consultant conversion
1000000

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Nu-Med Plus, Inc. (NUMD) Form 8-K — Oct 20, 2026: AI Analysis | Signal8